CIK 0001563665
- Non-accelerated filer
- Smaller reporting company
Harvard Apparatus Regenerative Technology, Inc.
Sign in to watch- Ticker
- HRGN
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455210462
- Phone
- +1 774-233-7300
- Business address
- 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
- Former names
- Biostage, Inc.
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at an average $1.56 ($7,775)
- 4 Open-market buy President and CEO bought 10,000 shares at $1.56 ($15,600)
- 4/A Open-market buy Director bought 18,000 shares at $1.36 ($24,401)
- 4 Open-market buy Director bought 18,000 shares at $1.36 ($24,401)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 2,393 shares at $2.01 ($4,817)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $3.01 ($30,052)
- 4 Open-market buy Director bought 9,000 shares at $2.95 ($26,525)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.70 ($17,000)
- 4 Open-market buy President and CEO bought 10,000 shares at $1.79 ($17,900)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.56 ($15,600)
Page 9 of 12 · 235 filings